Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5267648
Max Phase: Preclinical
Molecular Formula: C44H42ClN9O6S
Molecular Weight: 860.40
Associated Items:
ID: ALA5267648
Max Phase: Preclinical
Molecular Formula: C44H42ClN9O6S
Molecular Weight: 860.40
Associated Items:
Canonical SMILES: Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)NCCCCNC(=O)c1ccc(CNc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)cc1)c1nnc(C)n1-2
Standard InChI: InChI=1S/C44H42ClN9O6S/c1-23-24(2)61-44-36(23)38(27-13-15-29(45)16-14-27)49-32(39-52-51-25(3)53(39)44)21-35(56)46-19-4-5-20-47-40(57)28-11-9-26(10-12-28)22-48-31-8-6-7-30-37(31)43(60)54(42(30)59)33-17-18-34(55)50-41(33)58/h6-16,32-33,48H,4-5,17-22H2,1-3H3,(H,46,56)(H,47,57)(H,50,55,58)/t32-,33?/m0/s1
Standard InChI Key: XUUXQUUSZSAMLH-JEFWXSHNSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 860.40 | Molecular Weight (Monoisotopic): 859.2667 | AlogP: 5.53 | #Rotatable Bonds: 13 |
Polar Surface Area: 196.85 | Molecular Species: NEUTRAL | HBA: 12 | HBD: 4 |
#RO5 Violations: 3 | HBA (Lipinski): 15 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 11.59 | CX Basic pKa: 4.44 | CX LogP: 4.82 | CX LogD: 4.82 |
Aromatic Rings: 5 | Heavy Atoms: 61 | QED Weighted: 0.09 | Np Likeness Score: -0.97 |
1. Ding M, Shao Y, Sun D, Meng S, Zang Y, Zhou Y, Li J, Lu W, Zhu S.. (2023) Design, synthesis, and biological evaluation of BRD4 degraders., 78 [PMID:36563515] [10.1016/j.bmc.2022.117134] |
Source(1):